½ÃÀ庸°í¼­
»óǰÄÚµå
1463647

ºÏ¹ÌÀÇ ´ëµ¿¸ÆÆÇ¸· ġȯ¼ú ±â±â : ½ÃÀå ¿¹Ãø(2030³â) - ºÎ¹®º° ºÐ¼®

North America Aortic Valve Replacement Devices Market Forecast to 2030 - Regional Analysis - by Product, Surgery, and End User .

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Insight Partners | ÆäÀÌÁö Á¤º¸: ¿µ¹® 86 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ºÏ¹Ì ´ëµ¿¸ÆÆÇ¸· ġȯ¼ú ±â±â(Aortic Valve Replacement Devices) ½ÃÀåÀº 2022³â 33¾ï 3,333¸¸ ´Þ·¯¿¡¼­ 2030³â¿¡´Â 86¾ï 328¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. 2022-2030³âÀÇ CAGRÀº 12.6%·Î ÃßÁ¤µË´Ï´Ù.

´ëµ¿¸ÆÆÇ¸· ġȯ¼ú °Ç¼ö Áõ°¡°¡ ºÏ¹Ì ´ëµ¿¸ÆÆÇ¸· ġȯ¼ú ±â±â ½ÃÀåÀ» µÞ¹Þħ

ÃÖ±Ù ¼¼°è ´ëµ¿¸ÆÆÇ¸· ġȯ¼úÀÇ ¼ö°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. The Texas Herat Institute°¡ ¹ßÇ¥ÇÑ µ¥ÀÌÅÍ¿¡ µû¸£¸é ¹Ì±¹¿¡¼­´Â ¿¬°£ ¾à 10¸¸ 6,000°ÇÀÇ ½ÉÀå ÆÇ¸· ¼ö¼úÀÌ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù. ½Â¸ðÆÇ ¶Ç´Â ´ëµ¿¸ÆÆÇÀº ÀÌ·¯ÇÑ ¼ö¼úÀÇ °ÅÀÇ ¸ðµç ºÎºÐ¿¡¼­ ¼ö¸®µÇ°Å³ª ´ëüµË´Ï´Ù. ÀÌ·¯ÇÑ ±ÞÁõÀº ÀÇ·á±â¼ú Áøº¸, Àα¸ÀÇ °í·ÉÈ­, ½ÉÀå °ü·Ã Áúȯ¿¡ ´ëÇÑ ÀǽÄÀÇ Çâ»ó µî ¿©·¯ ¿äÀο¡ ±âÀÎÇϰí ÀÖ½À´Ï´Ù. ´ëµ¿¸Æ ÆÇ¸· ġȯ¼úÀº ´ëµ¿¸Æ ÆÇ¸· ÇùÂøÁõ°ú ¿ª·ùÁõÀÇ Ä¡·á¿¡ ÀÚÁÖ »ç¿ëµÇ´Â Áß¿äÇÑ ÀýÂ÷ÀÔ´Ï´Ù. ÀÇ·á°¡ °è¼Ó ÁøÈ­ÇÔ¿¡ µû¶ó ÀÌ·¯ÇÑ ¼ö¼úÀº º¸´Ù ¾ÈÀüÇϰí ÀÌ¿ëÇϱ⠽¬¿öÁö°í ´ëµ¿¸ÆÆÇ ÁúȯÀ» ¾Î°í Àִ ȯÀÚÀÇ ¿¹ÈÄ °³¼±°ú »îÀÇ Áú Çâ»ó¿¡ ±â¿©ÇÒ °ÍÀ¸·Î ±â´ëµË´Ï´Ù. ÀÇ·á ½Ã½ºÅÛÀº ÀÌ·¯ÇÑ ¼ö¼ú °³ÀÔ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ ÀûÀÀÇϰí ÀÖÀ¸¸ç, ½ÉÇ÷°ü°èÀÇ °Ç°­ °ü¸®¿¡¼­ ¿¹¹æ Á¶Ä¡¿Í Á¶±â ¹ß°ßÀÇ Á߿伺À» °­Á¶ÇÕ´Ï´Ù.

ºÏ¹Ì ´ëµ¿¸ÆÆÇ¸· ġȯ¼ú ±â±â ½ÃÀå °³¿ä

ºÏ¹Ì ´ëµ¿¸ÆÆÇ¸· ġȯ¼ú ±â±â ½ÃÀåÀº ¹Ì±¹, ij³ª´Ù, ¸ß½ÃÄÚ·Î ±¸ºÐµË´Ï´Ù. ÀÌ Áö¿ª ½ÃÀå ¼ºÀåÀº ½ÉÀå ÁúȯÀÇ À¯º´·ü »ó½Â, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ¿¬±¸ °³¹ß Ȱµ¿, ½ÅÁ¦Ç° Ãâ½Ã Áõ°¡¿¡ ±âÀÎÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¼ö¸¹Àº ½ÉÀå¼¾ÅÍ, Àü¹®ÀÇ·á¼¾ÅÍ, ¿Ü·¡¼ö¼ú¼¾ÅÍ, À¯¸®ÇÑ »óȯ ½Ã³ª¸®¿À°¡ 2022-2030³â ºÏ¹Ì ´ëµ¿¸ÆÆÇ¸· ġȯ¼ú ±â±â ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÏ¹Ì ´ëµ¿¸ÆÆÇ¸· ġȯ¼ú ±â±â ½ÃÀå ¼öÀͰú 2030³â±îÁö ¿¹Ãø(±Ý¾×)

ºÏ¹Ì ´ëµ¿¸ÆÆÇ¸· ġȯ¼ú ±â±â ½ÃÀå ¼¼ºÐÈ­

ºÏ¹Ì ´ëµ¿¸ÆÆÇ¸· ġȯ¼ú ±â±â ½ÃÀåÀº Á¦Ç°, ¼ö¼ú, ÃÖÁ¾ »ç¿ëÀÚ ¹× ±¹°¡º°·Î ºÐ·ùµË´Ï´Ù.

Á¦Ç°º°·Î, ºÏ¹Ì ´ëµ¿¸ÆÆÇ ġȯ¼ú ±â±â ½ÃÀåÀº ¹«ºÀÇÕ ¹ëºê¿Í ±â°è½Ä ¹ëºê·Î ±¸ºÐµË´Ï´Ù. 2022³â ºÏ¹Ì ´ëµ¿¸ÆÆÇ¸· ġȯ¼ú ±â±â ½ÃÀåÀº ¹«ºÀÇÕ ¹ëºê°¡ Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

¼ö¼úÀ» ±â¹ÝÀ¸·Î ºÏ¹Ì ´ëµ¿¸ÆÆÇ¸· ġȯ¼ú ±â±â ½ÃÀåÀº ÃÖ¼Ò Ä§½À ¼ö¼ú°ú °³º¹ ¼ö¼ú·Î ³ª´¹´Ï´Ù. 2022³â¿¡´Â ÃÖ¼Ò Ä§½À ¼ö¼ú ºÎ¹®ÀÌ ºÏ¹Ì ´ëµ¿¸ÆÆÇ¸· ġȯ¼ú ±â±â ½ÃÀå¿¡¼­ ´õ Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

ÃÖÁ¾ »ç¿ëÀÚº°·Î´Â ºÏ¹Ì ´ëµ¿¸ÆÆÇ¸· ġȯ¼ú ±â±â ½ÃÀåÀº º´¿ø ¹× Ŭ¸®´Ð, ¿Ü·¡¼ö¼ú¼¾ÅÍ µîÀ¸·Î ±¸ºÐµË´Ï´Ù. º´¿ø ¹× Ŭ¸®´Ð ºÎ¹®Àº 2022³â ºÏ¹Ì ´ëµ¿¸ÆÆÇ¸· ġȯ¼ú ±â±â ½ÃÀå ³» ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

±¹°¡º°·Î º¸¸é ºÏ¹Ì ´ëµ¿¸ÆÆÇ¸· ġȯ¼ú ±â±â ½ÃÀåÀº ¹Ì±¹, ij³ª´Ù, ¸ß½ÃÄÚ·Î ºÐ·ùµË´Ï´Ù. ¹Ì±¹Àº 2022³â ºÏ¹Ì ´ëµ¿¸ÆÆÇ¸· ġȯ¼ú ±â±â ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù.

Abbott Laboratories, Artivion Inc, Boston Scientific Corp, Braile Biomedica Industry, Commerce and Representations Ltd, Edwards Lifesciences Corp, LivaNova Plc, Medtronic Plc, JenaValve Technology Inc, Venus MedTech HangZhou Inc´Â »ç¾÷À» Àü°³Çϰí ÀÖ´Â ´ë±â¾÷ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ÁÖ¿ä ÀλçÀÌÆ®

Á¦3Àå Á¶»ç ¹æ¹ý

  • Á¶»ç ¹üÀ§
  • 2Â÷ Á¶»ç
  • 1Â÷ Á¶»ç

Á¦4Àå ºÏ¹ÌÀÇ ´ëµ¿¸ÆÆÇ¸· ġȯ¼ú ±â±â ½ÃÀå »óȲ

  • ¼Ò°³
  • PEST ºÐ¼®
    • ºÏ¹ÌÀÇ PEST ºÐ¼®
  • »ýÅÂ°è ºÐ¼®
    • ¹ë·ùüÀÎÀÇ º¥´õ À϶÷
  • ÆÄÀÌÇÁ¶óÀÎ ºÐ¼®

Á¦5Àå ºÏ¹ÌÀÇ ´ëµ¿¸ÆÆÇ ġȯ¼ú ±â±â ½ÃÀå : ÁÖ¿ä »ê¾÷ ¿ªÇÐ

  • ÁÖ¿ä ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ´ëµ¿¸ÆÆÇ ġȯ ¼ö¼ú °Ç¼ö Áõ°¡
    • ÃÖ¼Ò Ä§½À ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • Á¦Ç° ¸®ÄÝ
    • ±¸Á¶ ½ÉÀå ÀåÄ¡¿¡ °üÇÑ ¾ö°ÝÇÑ ±ÔÁ¤
  • ½ÃÀå ±âȸ
    • ´ëµ¿¸ÆÆÇ¸· ġȯ¼ú ±â±âÀÇ Áøº¸
  • ÇâÈÄ µ¿Çâ
    • ÀÓ»ó ¿¬±¸ Áõ°¡
  • ¿µÇ⠺м®

Á¦6Àå ´ëµ¿¸ÆÆÇ¸· ġȯ¼ú ±â±â ½ÃÀå : ºÏ¹Ì ½ÃÀå ºÐ¼®

  • ºÏ¹ÌÀÇ ´ëµ¿¸ÆÆÇ¸· ġȯ¼ú ±â±â ½ÃÀå ¸ÅÃâ¾×(2022-2030³â)

Á¦7Àå ºÏ¹ÌÀÇ ´ëµ¿¸ÆÆÇ¸· ġȯ¼ú ±â±â ½ÃÀå ¸ÅÃâ ¹× ¿¹Ãø(-2030³â) : Á¦Ç°º°

  • ¼Ò°³
  • ºÏ¹Ì ´ëµ¿¸ÆÆÇ ġȯ¼ú ±â±â ½ÃÀå(2022³â, 2030³â) : Á¦Ç°º° ¸ÅÃâ Á¡À¯À²(%)
  • ±â°è
  • ¹«ºÀÇÕ

Á¦8Àå ºÏ¹ÌÀÇ ´ëµ¿¸ÆÆÇ ġȯ¼ú ±â±â ½ÃÀå ¸ÅÃâ ¹× ¿¹Ãø(-2030³â) : ¼ö¼úº°

  • ¼Ò°³
  • ºÏ¹Ì ´ëµ¿¸ÆÆÇ ġȯ¼ú ±â±â ½ÃÀå(2022³â, 2030³â) : ¼ö¼úº° ¸ÅÃâ Á¡À¯À²(%)
  • °³º¹ ¼ö¼ú
  • ÃÖ¼Ò Ä§½À ¼ö¼ú

Á¦9Àå ºÏ¹ÌÀÇ ´ëµ¿¸ÆÆÇ ġȯ¼ú ±â±â ½ÃÀå ¸ÅÃâ ¹× ¿¹Ãø(-2030³â) : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¼Ò°³
  • ºÏ¹ÌÀÇ ´ëµ¿¸ÆÆÇ ġȯ¼ú ±â±â ½ÃÀå(2022³â, 2030³â) : ÃÖÁ¾ »ç¿ëÀÚº° ¸ÅÃâ Á¡À¯À²(%)
  • º´¿ø ¹× Ŭ¸®´Ð
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • ±âŸ

Á¦10Àå ºÏ¹ÌÀÇ ´ëµ¿¸ÆÆÇ¸· ġȯ¼ú ±â±â ½ÃÀå : ±¹°¡º° ºÐ¼®

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ

Á¦11Àå ºÏ¹ÌÀÇ ´ëµ¿¸ÆÆÇ¸· ġȯ¼ú ±â±â ½ÃÀå »ê¾÷ Á¤¼¼

  • ¼Ò°³
  • ºÏ¹Ì ´ëµ¿¸ÆÆÇ ġȯ¼ú ±â±â ½ÃÀå ¼ºÀå Àü·«
  • À¯±âÀû ¼ºÀå Àü·«
  • ¹«±âÀû ¼ºÀå Àü·«

Á¦12Àå ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • Abbott Laboratories
  • Medtronic Plc
  • Boston Scientific Corp
  • LivaNova Plc
  • Edwards Lifesciences Corp
  • Braile Biomedica Industry, Commerce and Representations Ltd
  • Artivion Inc
  • JenaValve Technology Inc
  • Venus MedTech HangZhou Inc

Á¦13Àå ºÎ·Ï

LYJ

The North America aortic valve replacement devices market is expected to grow from US$ 3,333.33 million in 2022 to US$ 8,603.28 million by 2030. It is estimated to grow at a CAGR of 12.6% from 2022 to 2030.

Rising Number of Aortic Valve Replacement Surgeries Fuels North America Aortic Valve Replacement Devices Market

There has been a significant increase in the number of aortic valve replacement surgeries performed worldwide recently. According to data published by The Texas Herat Institute, ~106,000 heart valve procedures are performed annually in the US. The mitral or aortic valves are repaired or replaced in almost all of these procedures. This surge can be attributed to several factors, including advancements in medical technology, an aging population, and improved awareness of heart-related conditions. Aortic valve replacement is a critical procedure often used to treat aortic valve stenosis or regurgitation, conditions that can lead to serious complications if left untreated. As medical science continues to evolve, these surgeries are expected to become even safer and more accessible, contributing to better patient outcomes and improved quality of life for those affected by aortic valve diseases. Healthcare systems are adapting to accommodate this growing demand for surgical interventions, emphasizing the importance of preventive measures and early detection in managing cardiovascular health.

North America Aortic Valve Replacement Devices Market Overview

The North America aortic valve replacement devices market is segmented into the US, Canada, and Mexico. The market growth in the region is attributed to the rising prevalence of heart diseases and increasing number of regulatory approvals, R&D activities, and new product launches. Additionally, a large number of cardiac centers, specialty care centers, and ambulatory surgical centers, as well as favorable reimbursement scenarios, are expected to boost the aortic valve replacement devices market growth in North America during 2022-2030.

North America Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Million)

North America Aortic Valve Replacement Devices Market Segmentation

The North America aortic valve replacement devices market is segmented into product, surgery, end user, and country.

Based on product, the North America aortic valve replacement devices market is segmented into sutureless valve and mechanical valve. The sutureless valve held a larger North America aortic valve replacement devices market share in 2022.

Based on surgery, the North America aortic valve replacement devices market is segmented into minimally invasive surgery and open surgery. The minimally invasive surgery segment held a larger North America aortic valve replacement devices market share in 2022.

Based on end user, the North America aortic valve replacement devices market is segmented into hospitals & clinics, ambulatory surgical centers, and others. The hospitals & clinics segment held the largest North America aortic valve replacement devices market share in 2022.

Based on country, the North America aortic valve replacement devices market has been categorized into the US, Canada, and Mexico. The US dominated the North America aortic valve replacement devices market in 2022.

Abbott Laboratories; Artivion Inc; Boston Scientific Corp; Braile Biomedica Industry, Commerce and Representations Ltd; Edwards Lifesciences Corp; LivaNova Plc; Medtronic Plc; JenaValve Technology Inc; and Venus MedTech HangZhou Inc; are some of the leading companies operating in the North America aortic valve replacement devices market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Aortic Valve Replacement Devices Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain
  • 4.4 Pipeline Analysis

5. North America Aortic Valve Replacement Devices Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Rising Number of Aortic Valve Replacement Surgeries
    • 5.1.2 Increasing Demand for Minimally Invasive Techniques
  • 5.2 Market Restraints
    • 5.2.1 Product Recalls
    • 5.2.2 Stringent Regulations Regarding Structure Heart Devices
  • 5.3 Market Opportunities
    • 5.3.1 Advancements in Aortic Valve Replacement Devices
  • 5.4 Future Trends
    • 5.4.1 Increasing Number of Clinical Studies
  • 5.5 Impact Analysis:

6. Aortic Valve Replacement Devices Market - North America Market Analysis

  • 6.1 North America Aortic Valve Replacement Devices Market Revenue (US$ Mn), 2022 - 2030

7. North America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 - by Product

  • 7.1 Overview
  • 7.2 North America Aortic Valve Replacement Devices Market Revenue Share, by Product 2022 & 2030 (%)
  • 7.3 Mechanical Valve
    • 7.3.1 Overview
    • 7.3.2 Mechanical Valve: North America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Sutureless Valve
    • 7.4.1 Overview
    • 7.4.2 Sutureless Valve: North America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 - by Surgery.

  • 8.1 Overview
  • 8.2 North America Aortic Valve Replacement Devices Market Revenue Share, by Surgery, 2022 & 2030 (%)
  • 8.3 Open Surgery
    • 8.3.1 Overview
    • 8.3.2 Open Surgery: North America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Minimally Invasive Surgery
    • 8.4.1 Overview
    • 8.4.2 Minimally Invasive Surgery: North America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 - by End User.

  • 9.1 Overview
  • 9.2 North America Aortic Valve Replacement Devices Market Revenue Share, by End User, 2022 & 2030 (%)
  • 9.3 Hospitals & Clinics
    • 9.3.1 Overview
    • 9.3.2 Hospitals & Clinics: North America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Ambulatory Surgery Centers
    • 9.4.1 Overview
    • 9.4.2 Ambulatory Surgery Centers : North America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Others
    • 9.5.1 Overview
    • 9.5.2 Others: North America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Aortic Valve Replacement Devices Market - Country Analysis

  • 10.1 North America: Aortic Valve Replacement Devices Market
    • 10.1.1 Overview
    • 10.1.2 North America: North America Aortic Valve Replacement Devices Market, by Country, 2022 & 2030 (%)
      • 10.1.2.1 US: Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 US: Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.1.3 US: Aortic Valve Replacement Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.1.2.1.4 US: Aortic Valve Replacement Devices Market, by Surgery, 2020-2030 (US$ Million)
        • 10.1.2.1.5 US: Aortic Valve Replacement Devices Market, by End User, 2020-2030 (US$ Million)
      • 10.1.2.2 Canada: Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Canada: Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.2.3 Canada: Aortic Valve Replacement Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.1.2.2.4 Canada: Aortic Valve Replacement Devices Market, by Surgery, 2020-2030 (US$ Million)
        • 10.1.2.2.5 Canada: Aortic Valve Replacement Devices Market, by End User, 2020-2030 (US$ Million)
      • 10.1.2.3 Mexico: Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 Mexico: Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.3.3 Mexico: Aortic Valve Replacement Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.1.2.3.4 Mexico: Aortic Valve Replacement Devices Market, by Surgery, 2020-2030 (US$ Million)
        • 10.1.2.3.5 Mexico: Aortic Valve Replacement Devices Market, by End User, 2020-2030 (US$ Million)

11. North America Aortic Valve Replacement Devices Market Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in North America Aortic Valve Replacement Devices Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Key Company Profiles

  • 12.1 Abbott Laboratories
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Medtronic Plc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Boston Scientific Corp
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 LivaNova Plc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Edwards Lifesciences Corp
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Braile Biomedica Industry, Commerce and Representations Ltd
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Artivion Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 JenaValve Technology Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Venus MedTech HangZhou Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦